Sign in
4

Changes in Ownership

Ensysce Biosciences, Inc. Filed Acc 0001144204-17-062468

Chief Financial Officer disposed of 733 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Peng George Chief Financial Officer 2017-12-05 Other disposition −733 100,265 D
Loading xslF345X03/tv480818_4.xml…